|Last Price$54.05||Day Change (%)0.06%|
|Open Price$54.22||Day Change ($)0.03|
|Day Range53.92–54.27||52-Week Range44.62–61.33|
As of Mon 10/20/2014 04:13 PM EST | USD
Research and Markets: Uveitis Market Analysis 2014-2015 - API Manufacturers and Phase III Pipeline Assessment
PDI, Inc. Announces Appointment of Graham G. Miao, MBA, Ph.D. as Chief Financial Officer
Allied-Bristol Life Sciences Appoints Former Bristol-Myers Vice President Satish Jindal to Lead the Discovery of Drug Candidates From Leading Academic Institutions
NephroGenex Appoints Marco Taglietti, M.D. to Board of Directors
The sale to Bayer monetizes Merck's consumer unit at a strong valuation, and removes Merck from an area where it lacks scale.
American's managers have been busy buying unloved large caps.
Australia stocks fall ahead of China data
Light and Landis+Gyr unveil largest smart grid partnership in South America
With a rock-solid belief in their strategy, the managers of Homestead Value confidently go about their business.